spacer
home > ict > autumn 2009 > liability insurance: protection in the clinical trial setting
PUBLICATIONS
International Clinical Trials

Liability Insurance: Protection in the Clinical Trial Setting

 

Product liability insurance, in its purest form, does not normally include the liability of an unproven, unregulated product in its testing stages. Usually, this is not a problem for manufacturers, since products are not distributed until the company and regulators feel the products are safe under normal use circumstances.

In the case of pharmaceuticals, medical devices or diagnostics, this is not the case. Testing is normally conducted in phases that can span years. Especially in the later phases of testing during clinical trials, there may be significant, uninsured liabilities incurred by the drug sponsor. These potential liabilities have created the need for clinical trials liability insurance. While sometimes referred to as ‘products liability’, their intent is to restrict coverage to the trial itself.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
Harry Wallace is the Practice Leader for RCM&D’s Life Science and High Technology Group where he oversees the delivery of risk management products and services to these industries. He has over 30 years of experience in the insurance industry. Prior to becoming a broker, he was employed by the Chubb Group of Insurance Companies for 21 years where he held several senior level and management positions. Harry is a graduate of Texas A&M University. He holds a Certified Insurance Counselor designation and is a member of the Professional Liability Underwriting Society. Harry was recently recognised as one of six ‘Power Brokers’ for 2009 by Risk and Insurance magazine in the area of pharmaceuticals.
spacer
Harry Wallace
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics Strengthens Commercial Team With Three New Senior Hires

Cambridge, UK, 10 May 2022: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed three new hires to its commercial team. Evelyn Stevenson and Ravi Girdhar join as Director of Product Management and Director of Sales (EMEA), respectively, alongside Denise Emsden as Vice-President of People and Organizational Development. Following the closure of a £26 million GBP (c. $36 million USD) funding round in 20211, the appointments support the Company’s next stage of development to expand product research and development, international operations and sales in key global markets.
More info >>

White Papers

Pharmaceuticals and Healthcare Products

Turkish Cargo

Pharmaceuticals are requiring safe and reliable transportation for being highly temperature sensitive products. Thosepharmaceuticals are; diagnostics, vaccines drugs, sera, plasma, protein clinical trials, biotechnological material, pills and all kind of medicines. Turkish Cargo transports all kind of pharmaceuticals, and has been carrying out its operations of transporting and storing drugs and temperature-sensitive medical supplies successfully and with the experience of 80 years; since 1936.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement